BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8589366)

  • 1. Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor.
    Broxmeyer HE; Cooper S; Li ZH; Lu L; Song HY; Kwon BS; Warren RE; Donner DB
    Int J Hematol; 1995 Dec; 62(4):203-15. PubMed ID: 8589366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family.
    Broxmeyer HE; Cooper S; Li ZH; Lu L; Sarris A; Wang MH; Chang MS; Donner DB; Leonard EJ
    Ann Hematol; 1996 Jul; 73(1):1-9. PubMed ID: 8695717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.
    Ratajczak MZ; Ratajczak J; Machalinski B; Majka M; Marlicz W; Carter A; Pietrzkowski Z; Gewirtz AM
    Br J Haematol; 1998 Dec; 103(4):969-79. PubMed ID: 9886308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
    Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
    Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.
    Hattori K; Dias S; Heissig B; Hackett NR; Lyden D; Tateno M; Hicklin DJ; Zhu Z; Witte L; Crystal RG; Moore MA; Rafii S
    J Exp Med; 2001 May; 193(9):1005-14. PubMed ID: 11342585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
    Moore MA; Hattori K; Heissig B; Shieh JH; Dias S; Crystal RG; Rafii S
    Ann N Y Acad Sci; 2001 Jun; 938():36-45; discussion 45-7. PubMed ID: 11458524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
    Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
    Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment.
    Bautz F; Rafii S; Kanz L; Möhle R
    Exp Hematol; 2000 Jun; 28(6):700-6. PubMed ID: 10880756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.
    Oyama T; Ran S; Ishida T; Nadaf S; Kerr L; Carbone DP; Gabrilovich DI
    J Immunol; 1998 Feb; 160(3):1224-32. PubMed ID: 9570538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies.
    Bellamy WT
    Semin Oncol; 2001 Dec; 28(6):551-9. PubMed ID: 11740808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
    Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
    Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow.
    Dührsen U; Martinez T; Vohwinkel G; Ergün S; Sun L; McMahon G; Dürig J; Hossfeld DK; Fiedler W
    Growth Factors; 2001; 19(1):1-17. PubMed ID: 11678206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat.
    Xie B; Tam NN; Tsao SW; Wong YC
    Br J Cancer; 1999 Dec; 81(8):1335-43. PubMed ID: 10604730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
    von Marschall Z; Cramer T; Höcker M; Burde R; Plath T; Schirner M; Heidenreich R; Breier G; Riecken EO; Wiedenmann B; Rosewicz S
    Gastroenterology; 2000 Nov; 119(5):1358-72. PubMed ID: 11054395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.